AHSCT For MS
Specializing In The Latest Advancements
An Effective Therapeutic Approach
Autologous Hematopoietic Stem Cell Transplantation (AHSCT) is a treatment process which involves extracting stem cells from a patient's blood stream, administering high doses of chemotherapy to eradicate the immune system, and then re-infusing the stem cells to allow for recovery of immune functioning. AHSCT resets the immune system and halts the inflammatory process that drives disease progression.
HOW IT CAN HELP
Proven Efficacy for Multiple Sclerosis
AHSCT is recognized as a safe and highly effective immune reconstitution therapy for people with multiple sclerosis (MS), particularly patients with relapsing-remitting MS (RRMS). The efficacy of AHSCT therapy has been demonstrated in several studies resulting in extended periods of disease remission, improvement in disability, and the absence of new MRI lesions.
While AHSCT is not a cure for MS itself, proper functioning of the immune system post-chemotherapy can prevent myelin deterioration, further damage to myelin and restore proper electrical flow within the nervous system.
Studies and clinical trials have shown that AHSCT is a safe and effective therapeutic approach to reduce or eliminate a series of relapses, cease further disease progression, and lessen effects of the disorder. The reasons for this therapy's success are its lower toxicity and ability to replace the immune system, which improves disability after treatment.
What You Can Expect
Stages Of Treatment
1. Questionnaire Review
Completed about 3 months before the exam
2. Pre-Transplant Exam
3–4 days of detailed evaluation before approval
3. Stem Cell Collection & Treatment Start
5–6 days depending on collection results
Become an ms warrior
Understanding Multiple Sclerosis and Its Progression
Multiple sclerosis is a chronic inflammatory disease of the central nervous system caused by an autoimmune response in which T-cells attack nerve cell components. It progresses gradually over time and can lead to significant mobility, sensory, and cognitive impairment. While modified therapies may help manage flare-ups, they do not stop disease progression or provide lasting results, often leaving patients dependent on ongoing and costly treatments.
